get a key
steadybase-$ company PMCB
account_id none on file
legal_name PharmaCyte Biotech, Inc.
ticker PMCB
cik 1157075
domain pharmacyte.com
entry_point_account_id none on file
name PharmaCyte Biotech Inc.
exchange Nasdaq
sector Health Care
hq Las Vegas, NV, United States
calls 0 filings 8 executives 4 family 0
why_nownone on file
callsnone on file
filings
to audit fees, fair value calculations and legal costs increase in travel and entertainment of $10,846, net of decreases in director compensation

filing / Sep 14, 2026 / receipt

Trujillo was appointed as our Chief Financial Officer. Mr. Trujillo has over three decades of experience in management, business, operations, and financial accounting.

filing / Jul 29, 2026 / receipt

Trujillo will serve as a member of our Board, from which he resigned on August 15, 2022, and as our Chief Financial Officer.

filing / Jul 29, 2026 / receipt

100 square feet of office space plus the use of certain shared facilities, such as a lobby, conference rooms, a kitchen and open workspaces.

filing / Jul 29, 2026 / receipt

Office Lease In January 2023, the Company entered into a month-to-month agreement of the Las Vegas office space, commencing on May 1, 2023.

filing / Jul 29, 2026 / receipt

our international expansion efforts, our ability to attract and retain employees and our business, prospects, operating results and financial

filing / Jul 29, 2026 / receipt

Office Lease In January 2023, the Company entered into a month-to-month agreement of the Las Vegas office space, commencing on May 1, 2023.

filing / Mar 17, 2026 / receipt

agreement of the Las Vegas office space, commencing on May 1, 2023. Additionally, the Company rents storage space pursuant to a month-to-month

filing / Mar 17, 2026 / receipt

executives
Kenneth L. Waggoner director - receipt
Mark Taggatz President and Chief Executive Officer - receipt
Martin Schmieg Chairman of the Board - receipt
Robert F. Ryan Chief Science Officer - receipt
familynone on file
upcomingnone on file
changes
2014-10-03 Chief Financial Officer, departed sec_8k
2014-10-03 President, departed sec_8k
2014-09-25 director, appointed sec_8k
2013-11-25 Chief Science Officer, appointed sec_8k
2011-02-03 President and Chief Executive Officer, appointed sec_8k
2009-03-26 Chairman of the Board, appointed sec_8k
2004-10-04 Director, departed sec_8k
2004-10-04 President and Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$